Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
05/26/2004 | CN1498650A Granule for artesian spring of stimulate milk secretion and preparing technique |
05/26/2004 | CN1498643A Method for preparing Chinese medica preparation for treating gynecopathy |
05/26/2004 | CN1151167C Purine derivatives |
05/26/2004 | CN1151155C 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
05/26/2004 | CN1150938C Capsule for treating gynaecologic inflammation, and its prepn. process |
05/26/2004 | CN1150920C Medicine for treating female dimacteric syndrome and its preparing process |
05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
05/25/2004 | US6740660 For amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to mammal |
05/25/2004 | US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
05/25/2004 | US6740645 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
05/25/2004 | US6740327 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
05/25/2004 | US6740309 Delivery of compounds for the treatment of migraine through an inhalation route |
05/25/2004 | US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products |
05/25/2004 | US6740307 Delivery of β-blockers through an inhalation route |
05/25/2004 | US6740306 Imidazotriazinone-containing compositions for nasal administration |
05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
05/25/2004 | CA2101871C Transdermic pharmaceutical preparation |
05/21/2004 | WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
05/21/2004 | WO2004041289A1 Cardiovascular protection using anti-aldosteronic progestins |
05/21/2004 | WO2004041288A1 Hormone replacement therapy with drospirenone |
05/21/2004 | WO2004041282A1 Receptor regulator |
05/21/2004 | WO2004041266A1 Receptor function controlling agent |
05/21/2004 | WO2004041259A1 Treatment of female sexual dysfunction |
05/21/2004 | WO2004011029A3 Pharmaceutical compositions for penis enlargement |
05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
05/21/2004 | WO2003020240A3 Therapeutic agent delivery tampon |
05/21/2004 | WO2002067952A8 Prophylactic teat treatment |
05/21/2004 | CA2505322A1 Receptor function regulator |
05/21/2004 | CA2504805A1 Receptor regulator |
05/20/2004 | US20040097597 Reducing side effects while elevating serum testosterone levels; having higher trans to cis ratio |
05/20/2004 | US20040097591 Increasing testosterone levels; sexual dysfunction; kits |
05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
05/20/2004 | US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
05/20/2004 | US20040097505 Reacting benzamide derivative with haloketone compound to form imidazotriazine compound |
05/20/2004 | US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders |
05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
05/20/2004 | US20040097477 For controlling male fertility in a mammal |
05/20/2004 | US20040097425 Peptide compounds |
05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
05/20/2004 | US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS) |
05/19/2004 | EP1420020A1 4-oxoimidazolidine-2-spiropiperidine derivative |
05/19/2004 | EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/19/2004 | EP1419773A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission |
05/19/2004 | EP1419394A2 Modulation of steroid hormone uptake |
05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
05/19/2004 | EP1419239A1 Mullerian inhibiting substance levels and ovarian response |
05/19/2004 | EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
05/19/2004 | EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
05/19/2004 | EP1418931A1 New drug |
05/19/2004 | EP1418921A1 Anti-tumour 2-alkoxyestradiol sulfamates |
05/19/2004 | EP1418920A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
05/19/2004 | EP1418907A1 Novel alpha adrenergic agents |
05/19/2004 | EP1418902A1 Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors |
05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
05/19/2004 | EP1418896A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
05/19/2004 | EP1418895A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
05/19/2004 | EP1220855B1 Anhydrous salt |
05/19/2004 | EP1204416A4 Carnitine analogues as topical, microbicidal spermicides |
05/19/2004 | EP1128811B1 Drug delivery device, especially for the delivery of progestins and estrogens |
05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
05/19/2004 | DE60100389T2 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung Fat-soluble substances containing granules, and processes for their preparation |
05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
05/19/2004 | DE10251028A1 Verwendung von Progesteron oder einem Progesteronrezeptor-Agonisten zur Hemmung der Steroidsynthese Use of progesterone or a progesterone receptor agonists for the inhibition of steroid synthesis |
05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
05/19/2004 | CN1498096A Condom with erectogenic composition |
05/19/2004 | CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction |
05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
05/19/2004 | CN1150175C Derivatives of 1,3,4-oxadiazolone |
05/19/2004 | CN1150023C Medicine for curing male infertility and female sterility |
05/19/2004 | CN1150009C Traditional Chinese medicine for female acyesis |
05/19/2004 | CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use |
05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
05/18/2004 | US6737084 Borage seed oil, angelica pubescens root, coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, and silica; topical |
05/18/2004 | US6737068 Wipe formulation |
05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
05/13/2004 | WO2004039396A1 Drug containing angiotensin convertase |
05/13/2004 | WO2004014271A9 Protection of the female reproductive system from natural and artificial insults |
05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
05/13/2004 | WO2002056903A9 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
05/13/2004 | US20040092744 Process for preparing crystalline form I of cabergoline |
05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
05/13/2004 | US20040092578 Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel |
05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
05/13/2004 | US20040092533 Central nervous system disorders; anxiolytic agents; anticonvulsants; cognition activators; side effect reduction |
05/13/2004 | US20040092525 Pirazino(aza)indole derivatives |
05/13/2004 | US20040092519 New treatment for hot flashes |
05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |